Rank Pharmaceuticals Limited
About Rank Pharmaceuticals Limited
Data last updated:
Rank Pharmaceuticals Limited is a public limited company based in Delhi, India, a subsidiary of J B Exports Private Ltd. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 June 1970 and has been in existence for over 56 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1970PLC005304.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹49 Lakh. It is led by directors including Vimla Kanaya Datwani and Nitin Kanya Datwani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 10 Golf Links, Delhi, India – 110003.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.73 Lakh. For the same year it recorded a net profit of ₹17.35 Lakh (net margin 62.6%) and EBITDA of ₹20.75 Lakh (EBITDA margin 74.8%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Rank Pharmaceuticals Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address10 Golf Links, Delhi, India – 110003
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rank Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rank Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Rank Pharmaceuticals Limited
FY 2025 filings availableRank Pharmaceuticals Limited reported revenue of ₹27.73 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20.75 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹17.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 74.8% | ||||
| Net Profit Margin | 62.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rank Pharmaceuticals Limited, buy the company report.
Board of directors of Rank Pharmaceuticals Limited
Rank Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vimla Kanaya Datwani Also directs: Deevim Property Advisory Partners LLP, Western Apparels Private Limited, B V M Engineering Industries Limited and 5 more | Director | 26 Jul 1985 | 41 Years 3 Months | Current |
| Nitin Kanya Datwani Also directs: Western Apparels Private Limited, B V M Engineering Industries Limited, J B Exports Private Ltd and 5 more | Director | 28 Feb 2005 | 21 Years 8 Months | Current |
| Deepak Datwani | Director | 28 Feb 2005 | 21 Years 8 Months | Current |
Peer comparison
Rank Pharmaceuticals Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tangible Pharmaceuticals Private Limited | ₹27.89 Lakh (FY 2025) | -30.0% | Mirzapur, Uttar Pradesh, India | |||
| Neptune Pharmaceuticals Private Limited | ₹27.79 Lakh (FY 2025) | 28.0% | Srinagar, Jammu and Kashmir, India | |||
| Rank Pharmaceuticals Limitedthis company | ₹27.73 Lakh (FY 2025) | ₹17.35 Lakh | 62.6% | Delhi, India | ||
| Dezire Healthcare Private Limited | ₹27.72 Lakh (FY 2025) | -17.0% | Ahmedabad, Gujarat, India | |||
| Samvee Pharmaceuticals Private Limited | ₹27.63 Lakh (FY 2022) | 5.0% | Hyderabad, Telangana, India | |||
| Ceedar Pharmaceuticals Private Limited | ₹27.63 Lakh (FY 2025) | -14.0% | Kanpur, Uttar Pradesh, India |
To see the full peer comparison of Rank Pharmaceuticals Limited, buy the company report.
Auditor
Rank Pharmaceuticals Limited is audited by OBHRAI KATARIA & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| OBHRAI KATARIA & ASSOCIATES | FY 2018 | 006571N |
Shareholding
The shareholding of Rank Pharmaceuticals Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Rank Pharmaceuticals Limited, buy the company report.
Legal cases
No court or tribunal cases involving Rank Pharmaceuticals Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rank Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rank Pharmaceuticals Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rank Pharmaceuticals Limited has 4 board changes on record since 1985: 3 appointments and 1 cessation. The latest: Mohinder Kumar Lakhwani ceased to be Director on 09 Jun 2014.
Frequently asked questions
Rank Pharmaceuticals is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 June 1970 (56+ years old) and is registered under CIN U24231DL1970PLC005304.
Rank Pharmaceuticals has 3 current directors:
- Vimla Kanaya Datwani - Director
- Nitin Kanya Datwani - Director
- Deepak Datwani - Director
The latest financial statements of Rank Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Rank Pharmaceuticals is U24231DL1970PLC005304. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rank Pharmaceuticals was incorporated on 02 June 1970, making it 56+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Rank Pharmaceuticals by revenue are Tangible Pharmaceuticals Private Limited, Neptune Pharmaceuticals Private Limited, Dezire Healthcare Private Limited, Samvee Pharmaceuticals Private Limited, Ceedar Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohinder Kumar Lakhwani ceased to be Director on 09 Jun 2014. Deepak Datwani was appointed as Director on 28 Feb 2005. Nitin Kanya Datwani was appointed as Director on 28 Feb 2005. Rank Pharmaceuticals has 4 board changes on record in total.
The registered office of Rank Pharmaceuticals is at 10 Golf Links, Delhi, India – 110003.
Rank Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Rank Pharmaceuticals is compliant as of 06 July 2026. The company is actively filing with the Registrar of Companies.
Rank Pharmaceuticals can be reached at its registered office: 10 Golf Links, Delhi, India – 110003.